A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies
Human Gene Therapy Methods · 2017-08 · 28 (4) · 163-176
DOI: 10.1089/hgtb.2017.096 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Gene Therapy Methods, 2017-08. Verfasst von Michael White und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Institute of Neuroscience, Newcastle University , Newcastle upon Tyne, United Kingdom. Hauptthemen laut MEDLINE: Guidelines as Topic. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1 Institute of Neuroscience, Newcastle University , Newcastle upon Tyne, United Kingdom.
- 2 Controlling Abnormal Network Dynamics using Optogenetics (CANDO) Consortium; Newcastle University , Newcastle upon Tyne, United Kingdom.
- 3 Department of Clinical Neurophysiology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, United Kingdom .
Zitieren
APA
White, M., Whittaker, R., Gándara, C., & Stoll, E. A. (2017). A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies. Human Gene Therapy Methods, 28(4), 163-176. https://doi.org/10.1089/hgtb.2017.096
Vancouver
White M, Whittaker R, Gándara C, Stoll EA. A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies. Human Gene Therapy Methods. 2017;28(4):163-176. doi:10.1089/hgtb.2017.096
BibTeX
@article{White2017,
author = {White, Michael and Whittaker, Roger and Gándara, Carolina and Stoll, Elizabeth A},
title = {A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies},
journal = {Human Gene Therapy Methods},
year = {2017},
volume = {28},
number = {4},
pages = {163--176},
doi = {10.1089/hgtb.2017.096}
}
EUVIMED